Please login to the form below

Not currently logged in
Email:
Password:

immunotherapies

This page shows the latest immunotherapies news and features for those working in and with pharma, biotech and healthcare.

Gilead agrees $21bn buyout of Immunomedics

Gilead agrees $21bn buyout of Immunomedics

In May, Gilead also announced its intent to partner with Arcus Biosciences on the development and commercialisation of next-generation cancer immunotherapies.

Latest news

More from news
Approximately 97 fully matching, plus 503 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    Liso-cel (lisocabtagene maraleucel, JCAR-017) is an immunotherapy comprised of autologous T cells genetically modified (via lentiviral vector) to express an anti-CD19 chimeric antigen receptor (CAR).

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    Indeed, 2019 was notable for Bristol-Myers Squibb’s acquisition of Celgene (which at a stroke bolstered its immunotherapy and oncology departments), as well as AbbVie’s acquisition of Allergan for ... Indeed, a key theme of the deals I have mentioned

  • It started with a miss It started with a miss

    However, we’re now moving into areas like immunotherapy and are on the edge of amazing innovations that will deliver great outcomes for patients.

  • A snapshot of Microbiotica A snapshot of Microbiotica

    An area of high interest is the discovery that responses to cancer immunotherapy are dependent on gut bacteria.

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    This view is shared by Chris Learn, who said immunotherapy studies are more prone to amendments than other types of research.

More from intelligence
Approximately 5 fully matching, plus 55 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 45 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 15 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics